stp_bannerlogocombo twitter facebook employee contact

Synergy Therapeutic Partners (STP) is a premier multi-centered clinical research organization that conducts highly efficient clinical trials for the pharmaceutical industry. "Our Vision is to provide best practices in clinical research for the advancement of modern day medicine." Our staff has a combined experience of 15 years offering the "We Care" attitude to our patients and stakeholders. We are committed to serving our communities with best practices and innovating ideas that will positively impact the medical industry.

Welcome to Synergy Therapeutic Partners

"Today’s Standard Treatment was Yesterday’s Clinical Trial"

Synergy Therapeutic Partners (STP) provides efficient and high quality Phase II, III, IV, and over-the-counter clinical trials to the pharmaceutical industry.  Our staff is committed to the advancement of modern medicine by providing our clients with reliable and expeditious services.  We serve as the connecting force in meeting and exceeding expectations in patient recruitment and regulatory processing.

lg_test_tubes

STP is committed to making clinical trials accessible across diverse populations and providing patients with optimal care.  We ensure each patient is well-informed about the clinical research process. Please feel free to view the FAQs to learn more about participating in a clinical trial.   

FDA Drug Info Rounds
Drug Name Review
FDA Drug Info Rounds pharmacists discuss FDA's ...

Communicating Benefit and ...
FDA Drug Info Rounds pharmacists talk about the ...

Communicating Drug Safety ...
FDA Drug Info Rounds pharmacists discuss the ...

Drug Shortages Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Evamist Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Proton Pump Inhibitors (PPIs) ...
FDA Drug Info Rounds pharmacists discuss new ...

Long-Acting Beta-Agonists ...
Long-Acting Beta-Agonists (LABAs), a class of ...

Single-Ingredient Oral ...
FDA Drug Info Rounds pharmacists discuss the ...

NIH News Releases
Follow that Cell
NIH challenges innovators with a half million ...

Monthly blood transfusions ...
NIH-funded study provides hope for children with ...

New NIH research awards to ...
It is estimated that 3 in 4 adults over age 65 ...

Test reliably detects ...
NIH-supported study suggests that early diagnosis ...

NIH announces the launch of 3 ...
ALCHEMIST is for patients with certain types of ...

Suspect gene corrupts neural ...
“Diseases of synapses” demo'd in a dish – ...

Experimental chikungunya ...
Vaccine developed by NIH scientists performs well ...

Scientists use lasers to ...
NIH-funded study explores how information flow in ...

Scientists detail urgent ...
HIV patients in developing countries facing new ...

Bioengineers create ...
Tissue model could change the way scientists ...

NIH and Italian scientists ...
An easy-to-use diagnostic test would let doctors ...

Year-round preventive ...
NIH-funded study shows benefit of monthly ...

NIH awards $14.5 million to ...
For the past several years, nanopore research has ...

NIH awards two new grants to ...
The three-year grants are part of the Human ...

NIH scientists visualize ...
The advance opens a new window to study protein ...

Genotype-Tissue Expression ...
Larger set of human tissues to be analyzed to ...

Early treatment benefits ...
NIH-funded study identifies factors contributing ...

African medical education is ...
PEPFAR, NIH jointly fund effort to strengthen ...

NIH launches new program to ...
Researchers will explore poorly understood genes, ...

NIH scientists find six new ...
Study shows power of combining big data analysis ...

NIH programs to focus on ...
Initiative features targeted investments in ...

NIBIB to Host Second Edward ...
Presentations from recent new investigators ...

TCGA researchers identify ...
Stomach cancers fall into four distinct molecular ...

Schizophrenia’s genetic ...
Suspect common variants soar from 30 to 108 – ...